Pretreatment improves outcomes with cyclosporine 0.1% in dry eye disease
Pretreatment with cyclosporine 0.05% enhances the anti-inflammatory effects of cyclosporine 0.1% in patients with dry eye disease (DED), while pretreatment with either cyclosporine 0.05% or a steroid improves treatment compliance and overall outcomes, according to a study. The retrospective study compared the effects of cyclosporine 0.1% eye drops in patients...
Read MoreQuizzes
Contact Info
© 2025 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved